Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

The use of hairpin DNA duplexes as HIV-1 fusion inhibitors: synthesis, characterization, and activity evaluation.

Xu L, Jiang X, Xu X, Zheng B, Chen X, Zhang T, Gao F, Cai L, Cheng M, Keliang Liu.

Eur J Med Chem. 2014 Jul 23;82:341-6. doi: 10.1016/j.ejmech.2014.05.068. Epub 2014 May 29.

PMID:
24927054
2.

DNA duplexes with hydrophobic modifications inhibit fusion between HIV-1 and cell membranes.

Xu L, Cai L, Chen X, Jiang X, Chong H, Zheng B, Wang K, He J, Chen W, Zhang T, Cheng M, He Y, Liu K.

Antimicrob Agents Chemother. 2013 Oct;57(10):4963-70. doi: 10.1128/AAC.00758-13. Epub 2013 Jul 29.

3.

DNA Triplex-Based Complexes Display Anti-HIV-1-Cell Fusion Activity.

Xu L, Zhang T, Xu X, Chong H, Lai W, Jiang X, Wang C, He Y, Liu K.

Nucleic Acid Ther. 2015 Aug;25(4):219-25. doi: 10.1089/nat.2015.0535.

4.

Structural basis of potent and broad HIV-1 fusion inhibitor CP32M.

Yao X, Chong H, Zhang C, Qiu Z, Qin B, Han R, Waltersperger S, Wang M, He Y, Cui S.

J Biol Chem. 2012 Aug 3;287(32):26618-29. doi: 10.1074/jbc.M112.381079. Epub 2012 Jun 7.

5.

Computer-aided design, synthesis, and biological activity evaluation of potent fusion inhibitors targeting HIV-1 gp41.

Tan JJ, Zhang B, Cong XJ, Yang LF, Liu B, Kong R, Kui ZY, Wang CX, Hu LM.

Med Chem. 2011 Jul;7(4):309-16.

PMID:
21568877
6.

Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.

Jiang S, Tala SR, Lu H, Zou P, Avan I, Ibrahim TS, Abo-Dya NE, Abdelmajeid A, Debnath AK, Katritzky AR.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6895-8. doi: 10.1016/j.bmcl.2011.08.081. Epub 2011 Sep 5.

PMID:
21978673
7.

Design of a novel HIV-1 fusion inhibitor that displays a minimal interface for binding affinity.

Oishi S, Ito S, Nishikawa H, Watanabe K, Tanaka M, Ohno H, Izumi K, Sakagami Y, Kodama E, Matsuoka M, Fujii N.

J Med Chem. 2008 Feb 14;51(3):388-91. doi: 10.1021/jm701109d. Epub 2008 Jan 16.

PMID:
18197613
9.

Peptide and non-peptide HIV fusion inhibitors.

Jiang S, Zhao Q, Debnath AK.

Curr Pharm Des. 2002;8(8):563-80. Review.

PMID:
11945159
10.

Identification of minimal sequence for HIV-1 fusion inhibitors.

Nishikawa H, Oishi S, Fujita M, Watanabe K, Tokiwa R, Ohno H, Kodama E, Izumi K, Kajiwara K, Naitoh T, Matsuoka M, Otaka A, Fujii N.

Bioorg Med Chem. 2008 Oct 15;16(20):9184-7. doi: 10.1016/j.bmc.2008.09.018. Epub 2008 Sep 10.

PMID:
18819810
11.

Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.

Mzoughi O, Gaston F, Granados GC, Lakhdar-Ghazal F, Giralt E, Bahraoui E.

ChemMedChem. 2010 Nov 8;5(11):1907-18. doi: 10.1002/cmdc.201000313.

PMID:
20922745
12.

d(TGGGAG) with 5'-nucleobase-attached large hydrophobic groups as potent inhibitors for HIV-1 envelop proteins mediated cell-cell fusion.

Chen W, Xu L, Cai L, Zheng B, Wang K, He J, Liu K.

Bioorg Med Chem Lett. 2011 Oct 1;21(19):5762-4. doi: 10.1016/j.bmcl.2011.08.007. Epub 2011 Aug 8.

PMID:
21873060
13.

Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652.

Chong H, Yao X, Qiu Z, Qin B, Han R, Waltersperger S, Wang M, Cui S, He Y.

J Biol Chem. 2012 Jun 8;287(24):20281-9. doi: 10.1074/jbc.M112.354126. Epub 2012 Apr 16.

14.

A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Murray EJ, Leaman DP, Pawa N, Perkins H, Pickford C, Perros M, Zwick MB, Butler SL.

J Virol. 2010 Jul;84(14):7288-99. doi: 10.1128/JVI.00535-10. Epub 2010 Apr 28.

15.

A homogeneous time-resolved fluorescence assay to identify inhibitors of HIV-1 fusion.

Smeulders L, Bunkens L, Vereycken I, Van Acker K, Holemans P, Gustin E, Van Loock M, Dams G.

Methods Mol Biol. 2013;1030:11-7. doi: 10.1007/978-1-62703-484-5_2.

PMID:
23821256
17.

Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.

Yu F, Lu L, Du L, Zhu X, Debnath AK, Jiang S.

Viruses. 2013 Jan 11;5(1):127-49. doi: 10.3390/v5010127. Review.

18.

Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusion.

He Y.

Curr Pharm Des. 2013;19(10):1800-9. Review.

PMID:
23092277
19.

[Oligodeoxynucleotides containing substituted 4-nitroindoles: synthesis and study of their DNA duplexes].

Timofeev EN, Kolganova NA, Smirnov IP, Kochetkova SV, Florent'ev VL.

Bioorg Khim. 2008 Mar-Apr;34(2):220-6. Russian.

PMID:
18522278
20.

Supplemental Content

Support Center